Keros Therapeutics, Inc.

This study tested whether adding KER-012 injections to standard medications helps adults with pulmonary arterial hypertension, a serious condition where blood pressure is high in the lungs. 113 participants received either KER-012 or a placebo shot every 4 weeks for 24 weeks whil…